MARINUS PHARMAC. DL-,001 revenue breakdown overview

MARINUS PHARMAC. DL-,001 revenue for the last year amounted to 28.08 M EUR, the most of which — 28.08 M EUR — came from its highest performing source at the moment, Therapeutics for Rare Seizures, the year earlier bringing 23.81 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought MARINUS PHARMAC. DL-,001 28.08 M EUR, and the year before that — 23.81 M EUR.